Navigation Links
Edison Nation Medical Seeks Product Innovations to Reduce the Incidence of Catheter-Associated Urinary Tract Infections (UTIs)
Date:7/15/2014

CHARLOTTE, N.C., July 15, 2014 /PRNewswire/ -- Edison Nation Medical, a healthcare innovation portal, today announced a worldwide search for medical device, app, and technology solutions aimed at reducing the incidence of Catheter-Associated Urinary Tract Infections (CA-UTIs). Innovation ideas can include, but are not limited to prevention, alternatives to catheterization, early detection, and detecting remotely through monitoring.  Edison Nation Medical will carefully evaluate all ideas submitted and will work to license the most promising innovations, sharing resulting licensing royalties with the inventor(s) involved.

The Edison Nation Medical innovation search is open to the public. Submissions should be made to Edison Nation Medical's confidential and secure online portal at www.EdisonNationMedical.com/UTI now through Monday, September 8, 2014. 

Urinary catheters are a commonly used medical device that allows for continuous urine drainage in patients.  Urinary catheters are used in the acute care setting in both men and women.  It is estimated that 15%-25% of patients may have a urinary catheter inserted sometime during their hospital stay, with most used on a short-term basis.  Once a catheter is placed, the percentage of patients developing bacteriuria (bacterial infection) increases from 3-10% for those catheterized less than a day to 90% in long-term catheterization

Urinary tract infections (UTIs) associated with urinary catheters account for approximately 40% of all hospital-acquired infections in the United States.  Infections resulting from catheter-associated UTIs are generally m
'/>"/>

SOURCE Edison Nation Medical
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Edison highlights the potential of GW Pharmaceuticals cannabinoid pipeline and furthers its US healthcare presence
2. Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
3. Edison Expands its Asia-Pac Pharmaceutical Presence with Launch of Coverage of Mesoblast
4. Edison expands international bio-pharmaceutical presence with launch of coverage of Onconova Therapeutics
5. Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
6. Edison initiates coverage of Derma Sciences
7. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
8. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
9. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
10. Edison Pharmaceuticals & Bambino Gesu Childrens Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
11. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 Valeritas, Inc., ... designed for patients with Type 2 diabetes, announced today ... Chain Excellence Award. The award was presented October 16 ... Columbus, Ohio . ... judged across a variety of metrics specifically targeted at ...
(Date:10/20/2014)... 20, 2014   Taiho Oncology, Inc. , ... Japan ), announced that the U.S. ... designation for TAS-102 (nonproprietary names: trifluridine and tipiracil ... for the treatment of refractory metastatic colorectal cancer ... rolling NDA submission to the FDA. According to ...
(Date:10/20/2014)... 20, 2014   Mary,s Medicinals today announced ... a 4-Star Sponsor of Operation Grow4Vets , a ... products, programs and services to assist them in living ... Key Facts: , An ever-increasing number of ... and effective treatment for pain, Post-traumatic Stress Disorder (PTSD) ...
Breaking Medicine Technology:Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3
... Trial for the Treatment of Pediatric Eosinophilic Esophagitis , ... Cephalon, Inc . (Nasdaq: CEPH ) and ... announced that the companies have signed an agreement providing ... stock of Ception. Under the terms of the ...
... of treatment, RAD001 halted tumor growth in 55% of ... Based on these promising data, Novartis will initiate a ... patients- Gastric cancer is the second leading cause of ... occurring in East AsiaEAST HANOVER, N.J., Jan. 13 ...
Cached Medicine Technology:Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 2RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 3RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 4RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 5RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 6
(Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
(Date:10/20/2014)... USA (PRWEB) October 20, 2014 Do ... track interventions? Here comes a wonderful app Metassessor for ... app development company helped its client “Intervention Development ... efficiently. The app is designed for iOS 4.3 or ... touch. This app is optimized for iPhone 5. It ...
(Date:10/19/2014)... York (PRWEB) October 19, 2014 Dr. ... Population Fund, welcomes news of a ceasefire agreement that ... more than 200 girls who were kidnapped from the ... have languished in captivity long enough, and it is ... and communities," stated Dr. Osotimehin. , "We owe it ...
(Date:10/19/2014)... Fancyflyingfox.com, an innovative company that provides many kinds of ... of 2014 mother of the bride dresses . ... with big discounts, up to 70% off. All consumers ... this special offer. , Owing to the company’s ... of the leading brands in the global market. A ...
(Date:10/19/2014)... (HealthDay News) -- New stem cell-based research could improve ... treatments, a new study suggests. Scientists used stem ... in a lab dish. They then transplanted the organoids ... disorders, according to the researchers. "This provides a ... that can cause intestinal failure, from genetic disorders appearing ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... the Bench,-, EL SEGUNDO, Calif., Oct. 16 ... solutions for microarray-based,research, announced today the release of ... that provides easy, fast and powerful platform,independent and ... data sets, simultaneously. NEXUS CGH easily supports ...
... The department of bioengineering at Clemson University has received ... Both the National Institutes of Health (NIH) and a ... (NSBRI www.nsbri.org ), are primary contributors of funds ... application. , The study addresses bone loss that occurs ...
... YORK, Oct. 16 Even though Americans pick up ... toothbrushes,may need a cleaning of their own. Celebrity Dentist ... says a new survey conducted by the,Philips Sonicare brand ... Listen to this report from Philips (NYSE: ...
... Unique Request Highlights December 2 Annual Wells Fargo Walk of Ages ... ... Home is,inviting everyone with the name of "Walker" in the United States to ... Walk of,Ages" on December 2 in Reseda. According to official census records there,are ...
... - BCL.P, VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ ... announce that it has entered into an ... (the "Arrangement,Agreement") with iCo Therapeutics Inc. ("iCo"). ... constitute Beanstalk,s,"Qualifying Transaction" as a capital pool ...
... children appear to have a lower risk of asthma ... a non-agricultural rural environment, according to a University of ... 13,524 asthmafree children aged less than 12 years in ... Youth (NLSCY) showed that children living in a farming ...
Cached Medicine News:Health News:BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization 2Health News:Clemson awarded $2M to study radiation-induced bone loss 2Health News:FORGET THE JONESES, This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named 'Walker' in the United States 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 2Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 3Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 4Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 5Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 6Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 7Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 8Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 9Health News:Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc. 10Health News:Farm kids have lower risk of asthma, study shows 2
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Medicine Products: